2018 annual financial data
Marker Therapeutics 2018 Net margin
Marker Therapeutics 2018 net margin with verified reported values.
Direct answer
Net margin was -71,826.36%.
Operating income was -148,172,000 USD and net income was -147,958,000 USD.
Operating cash flow was -14,479,916 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 205,994 USD
- Operating income
- -148,172,000 USD
- Net income
- -147,958,000 USD
- Operating cash flow
- -14,479,916 USD